Johnson Matthey PLC (LON:JMAT - Get Free Report) insider Liam Condon acquired 30 shares of the business's stock in a transaction on Wednesday, January 22nd. The shares were purchased at an average price of GBX 1,362 ($17.01) per share, for a total transaction of £408.60 ($510.18).
Johnson Matthey Stock Performance
Shares of JMAT traded up GBX 9 ($0.11) during mid-day trading on Friday, reaching GBX 1,376 ($17.18). 255,529 shares of the company's stock traded hands, compared to its average volume of 563,950. The company has a debt-to-equity ratio of 63.15, a quick ratio of 0.76 and a current ratio of 1.45. The business's 50-day moving average price is GBX 1,378.95 and its 200-day moving average price is GBX 1,509.48. The stock has a market capitalization of £2.40 billion, a P/E ratio of 2,372.41, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.95. Johnson Matthey PLC has a 12 month low of GBX 1,295.54 ($16.18) and a 12 month high of GBX 1,917.07 ($23.94).
Johnson Matthey (LON:JMAT - Get Free Report) last posted its earnings results on Wednesday, November 27th. The company reported GBX 57.40 ($0.72) EPS for the quarter. Johnson Matthey had a return on equity of 4.39% and a net margin of 0.84%. Equities analysts predict that Johnson Matthey PLC will post 173.4112903 earnings per share for the current year.
Johnson Matthey Cuts Dividend
The business also recently disclosed a dividend, which will be paid on Tuesday, February 4th. Stockholders of record on Thursday, December 5th will be paid a dividend of GBX 22 ($0.27) per share. This represents a dividend yield of 1.47%. The ex-dividend date of this dividend is Thursday, December 5th. Johnson Matthey's dividend payout ratio is presently 13,275.86%.
Analyst Upgrades and Downgrades
Several equities research analysts recently weighed in on JMAT shares. Jefferies Financial Group reiterated a "buy" rating and set a GBX 1,800 ($22.47) price objective on shares of Johnson Matthey in a research note on Tuesday, December 17th. Berenberg Bank reduced their price objective on Johnson Matthey from GBX 1,650 ($20.60) to GBX 1,500 ($18.73) and set a "hold" rating for the company in a research report on Thursday, November 28th.
View Our Latest Analysis on JMAT
Johnson Matthey Company Profile
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources.
Further Reading

Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.